Fusion Biopsy combines the superior sensitivity and specificity of MRI with the flexibility of Ultrasound to guide the targeted biopsy in Real Time
Fusion by a.D.i. is the first mobile MR/Fusion Target Biopsy service provider.
Why choose Fusion by a.D.i. for your practice?:
- 20-25% of male patients in your average Urology office have not been diagnosed with significant disease (CaP).
- Approximately 70-75% of prostate cancer is not found through standard Bx.
- We provide the most accurate diagnostic technology available to help physicians better diagnose significant disease, make more informed therapeutic decisions, and have better patient satisfaction.
What Fusion by a.D.i. provides for your practice:
- BioJet™ Technology Fusion hardware/software (with all Contoured MRI Scans)
- Full support of MR/TRUS Prostate Bx Fusion Cases
- Ultrasound tech support
- Detailed case reports with all recorded sites in a flash drive
*Interesting Feature:
"Use of MRI-US fusion biopsy allowed for the prediction of final prostate pathology with greater accuracy than that reported using conventional methods. If confirmed, improved knowledge of final pathology by fusion biopsy would have important clinical implications." - The Journal of Urology*